Economic Atlas
Companies/Xencor, Inc.
Company profile

Xencor, Inc.

NASDAQ: XNCR · Healthcare · Biotechnology
PublicHQ Pasadena, CA · Los AngelesCIK 0001326732Reports USD
#326 of 1,418 Healthcare companies by revenue60th-percentile growth
EA Score
59C
Revenue TTM
$97.4M
Rev growth YoY (TTM)
-29.2%
Net income (FY)
-$91.9M
Employees
260
as of 2026-08-10
Market cap
$1.5B
as of 2026-08-10

Financials — latest annual

SEC EDGAR · USD-normalized
ConceptUSDNativeFY
Revenue$125.6M$125.6M2025
Net income-$91.9M-$91.9M2025
Operating income-$177.5M-$177.5M2025
Total assets$875.5M$875.5M2025
Liabilities$239.9M$239.9M2025
Equity$635.6M$635.6M2025

Revenue trend

FY2020 – FY2025 · USD
FY20
FY20
FY20
FY21
FY22
FY23
FY24
FY25

Revenue by segment

Filed disclosures · FY2025
By product
Royalty64%
Milestone36%
By geography

Not disclosed.

The read

What is Xencor, Inc.’s revenue?

Xencor, Inc. booked $125.6M in FY2025 revenue, growing 14% year over year — faster than most Healthcare companies we track, at a -73.2% net margin.

Peers · Healthcare
Xtant Medical Holdings, Inc.74BUpHealth, Inc.——Niagen Bioscience Inc78B+Monte Rosa Therapeutics, Inc.54DAtara Biotherapeutics, Inc.44DCareCloud, Inc.73B
Neighbors
Los Angeles →
The Walt Disney Company$94.4B72BPublic Storage$4.8B80B+Southern California Gas Company PFD SER A 6%——Ares Management Corporation$5.6B68BLive Nation Entertainment, Inc.$25.2B76B+Rocket Lab USA, Inc.$601.8M50D
Key facts
CEOBassil I. Dahiyat
SectorHealthcare
IndustryBiotechnology
HeadquartersPasadena, CA
ExchangeNASDAQ: XNCR
Employees260
IPO date2013-12-03
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.